Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

letrozole

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Generic mfg.

Drug class:

Aromatase inhibitor

Related drugs:

‹

anastrozole (23)

exemestane (15)

anastrozole (23)

exemestane (15)

›

No biomarker	Breast Cancer	No biomarker	Breast Cancer	letrozole Sensitive: A1 - Approval letrozole Sensitive : A1	letrozole Sensitive: A1 - Approval letrozole Sensitive : A1
HR positive	Hormone Receptor Positive Breast Cancer	HR positive	Hormone Receptor Positive Breast Cancer	letrozole Sensitive: A1 - Approval letrozole Sensitive : A1	letrozole Sensitive: A1 - Approval letrozole Sensitive : A1
No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2
ER positive	HER2 Negative Breast Cancer	ER positive	HER2 Negative Breast Cancer	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2
HER-2 negative	HER2 Negative Breast Cancer	HER-2 negative	HER2 Negative Breast Cancer	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2
HER-2 negative	HER2 Negative Breast Cancer	HER-2 negative	HER2 Negative Breast Cancer	fulvestrant + letrozole Sensitive: A2 - Guideline fulvestrant + letrozole Sensitive : A2	fulvestrant + letrozole Sensitive: A2 - Guideline fulvestrant + letrozole Sensitive : A2
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2
HR positive	HER2 Negative Breast Cancer	HR positive	HER2 Negative Breast Cancer	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2
PGR positive	HER2 Negative Breast Cancer	PGR positive	HER2 Negative Breast Cancer	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2	letrozole Sensitive: A2 - Guideline letrozole Sensitive : A2
No biomarker	Endometrial Cancer	No biomarker	Endometrial Cancer	everolimus + letrozole Sensitive: A2 - Guideline everolimus + letrozole Sensitive : A2	everolimus + letrozole Sensitive: A2 - Guideline everolimus + letrozole Sensitive : A2
No biomarker	Ovarian Serous Adenocarcinoma	No biomarker	Ovarian Serous Adenocarcinoma	carboplatin + letrozole + pegylated liposomal doxorubicin Sensitive: A2 - Guideline carboplatin + letrozole + pegylated liposomal doxorubicin Sensitive : A2	carboplatin + letrozole + pegylated liposomal doxorubicin Sensitive: A2 - Guideline carboplatin + letrozole + pegylated liposomal doxorubicin Sensitive : A2